Anti-glomerular basement membrane antibody disease: A rare autoimmune disorder affecting the kidney and the lung

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 169-173

  Lahmer, Tobias ^a   Heemann, Uwe ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti; GBM disease; Goodpasture's disease; Immunosuppression; Plasmapherisis; Pulmonary hemorrhage; Renal failure; RPGN

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ACUTE KIDNEY FAILURE; AUTOIMMUNE DISEASE; COUGHING; DIALYSIS; DYSPNEA; END STAGE LIVER DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE ANTIBODY DISEASE; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HYPERTENSIVE CRISIS; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LUNG HEMORRHAGE; LUNG INFILTRATE; MALAISE; MICROSCOPY; PLASMAPHERESIS; REVIEW; T LYMPHOCYTE; URINALYSIS; WEIGHT REDUCTION; WESTERN BLOTTING;

AUTOANTIBODIES; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; LUNG DISEASES;

EID: 84870238960     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.04.002     Document Type: Review

References (42)

1. Pusey C.D. Anti-glomerular basement membrane disease. Kidney Int 2003, 64:1535-1550.
2. Bolton W.K. Goodpasture's syndrome. Kidney Int 1996, 50:1753-1766.
3. Kambham N. Crescentic glomerulonephritis: an update on Pauci-immune and anti-GBM diseases. Adv Anat Pathol 2012, 19:111-124.
4. Wilson C.B., Dixon F.J. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973, 3:74-89.
5. De Zoysa J., Taylor D., Thein H., Yehia M. Incidence and features of dual anti-GBM-positive and ANCA-positive patients. Nephrology (Carlton) 2011, 16:725-729.
6. Segelmark M., Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010, 9:366-371.
7. Kalluri R., Wilson C.B., Weber M., et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 1995, 6:1178-1185.
8. Tarzi R.M., Cook H.T., Pusey C.D. Crescentic glomerulonephritis: new aspects of pathogenesis. Semin Nephrol 2011, 31:361-368.
9. Merkel F., Kalluri R., Marx M., et al. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int 1996, 49:1127-1133.
10. Pedchenko V., Bondar O., Fogo A.B., et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010, 363:343-354.
11. Phelps R.G., Rees A.J. The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 1999, 56:1638-1653.
12. Kluth D.C., Rees A.J. Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999, 10:2446-2453.
13. Lazor R., Bigay-Gamé L., Cottin V., et al. Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP), Swiss Group for Interstitial and Orphan Lung Diseases (SIOLD). Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore) 2007, 86:181-193.
14. Cui Z., Zhao J., Jia X.Y., Zhu S.N., Zhao M.H. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients. Am J Kidney Dis 2011, 57:575-582.
15. Turner A.N., Rees A.J. Antiglomerular basement disease. Oxford textbook of clinical nephrology 2005, 579-600. Oxford University Press, Oxford. 3rd ed. A.M. Davison, J.S. Cameron, J.-P. Grunfeld, C. Ponticelli, E. Ritz, C.G. Winearls, C. van Ypersele (Eds.).
16. Litwin C.M., Mouritsen C.L., Wilfahrt P.A., Schroder M.C., Hill H.R. Anti-glomerular basement membrane disease: role of enzyme-linked immunosorbent assays in diagnosis. Biochem Mol Med 1996, 59:52-56.
17. Sinico R.A., Radice A., Corace C., Sabadini E., Bollini B. Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 2006, 21:397-401.
18. Hellmark T., Niles J.L., Collins A.B., McCluskey R.T., Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997, 8:376-385.
19. Levy J.B., Hammad T., Coulthart A., Dougan T., Pusey C.D. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004, 66:1535-1540.
20. Rutgers A., Slot M., van Paassen P., et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005, 46:253-262.
21. Jindal K.K. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. Kidney Int Suppl 1999, 70:33-40.
22. Levy J.B., Turner A.N., Rees A.J., Pusey C.D. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134:1033-1042.
23. Couser W.G. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988, 11:449-464.
24. Cui Z., Zhao J., Jia X.Y., et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center chinese cohort study. Medicine (Baltimore) 2011, 90:303-311.
25. Sanchez A.P., Ward D.M. Therapeutic apheresis for renal disorders. Semin Dial 2012, 25:119-131.
26. Johnson J.P., Moore J., Austin H.A., et al. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985, 64:219-227.
27. Lockwood C.M., Rees A.J., Pearson T.A., et al. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1976, 1:711-715.
28. Daly C., Conlon P.J., Medwar W., Walshe J.J. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail 1996, 18:105-112.
29. de Torrente A., Popovtzer M.M., Guggenheim S.J., Schrier R.W. Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy. Ann Intern Med 1975, 83:218-219.
30. Jennette J.C. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003, 63:1164-1177.
31. Kotanko P., Pusey C.D., Levy J.B. Recurrent glomerulonephritis following renal transplantation. Transplantation 1997, 63:1045-1052.
32. Denton M.D., Singh A.K. Recurrent and de novo glomerulonephritis in the renal allograft. Semin Nephrol 2000, 20:164-175.
33. Heemann U., Abramowicz D., Spasovski G., et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. European Renal Best Practice Work Group on Kidney Transplantation. Nephrol Dial Transplant 2011, 26:2099-2106.
34. Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 2003, 18:1260-1265.
35. Levy J.B., Pusey C.D. Still a role for plasma exchange in rapidly progressive glomerulonephritis?. J Nephrol 1997, 10:7-13.
36. Maxwell A.P., Nelson W.E., Hill C.M. Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane. Br Med J 1988, 297:333-334.
37. Flores J.C., Taube D., Savage C.O., et al. Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet 1986, 1:5-8.
38. Cohen L.H., Wilson C.B., Freeman R.M. Goodpasture syndrome: recovery after severe renal insufficiency. Arch Intern Med 1976, 136:835-837.
39. Levy J.B., Lachmann R.H., Pusey C.D. Recurrent Goodpasture's disease. Am J Kidney Dis 1996, 27:573-578.
40. Levy J.B., Lachmann R.H., Pusey C.D. Recurrent Goodpasture's disease. Am J Kidney Dis 1996, 27:573-578.
41. Clin Exp Nephrol 2008, 12:339-347.
42. Hind C.R., Bowman C., Winearls C.G., Lockwood C.M. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. Clin Nephrol 1984, 21:244-246.